These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1981583)
1. Effect on cerebral blood flow of orally administered indomethacin-loaded poly(isobutylcyanoacrylate) and poly(DL-lactide) nanocapsules. Ammoury N; Fessi H; Devissaguet JP; Allix M; Plotkine M; Boulu RG J Pharm Pharmacol; 1990 Aug; 42(8):558-61. PubMed ID: 1981583 [TBL] [Abstract][Full Text] [Related]
2. Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats. Ammoury N; Fessi H; Devissaguet JP; Dubrasquet M; Benita S Pharm Res; 1991 Jan; 8(1):101-5. PubMed ID: 2014197 [TBL] [Abstract][Full Text] [Related]
3. In vitro release kinetic pattern of indomethacin from poly(D,L-lactide) nanocapsules. Ammoury N; Fessi H; Devissaguet JP; Puisieux F; Benita S J Pharm Sci; 1990 Sep; 79(9):763-7. PubMed ID: 2273454 [TBL] [Abstract][Full Text] [Related]
4. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. Miyazaki S; Takahashi A; Kubo W; Bachynsky J; Löebenberg R J Pharm Pharm Sci; 2003; 6(2):238-45. PubMed ID: 12935436 [TBL] [Abstract][Full Text] [Related]
5. In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion. Watnasirichaikul S; Rades T; Tucker IG; Davies NM J Pharm Pharmacol; 2002 Apr; 54(4):473-80. PubMed ID: 11999123 [TBL] [Abstract][Full Text] [Related]
6. Influence of poly(DL-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit. Fawaz F; Bonini F; Guyot M; Lagueny AM; Fessi H; Devissaguet JP Pharm Res; 1993 May; 10(5):750-6. PubMed ID: 8321841 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic evaluation of indomethacin nanocapsules. Andrieu V; Fessi H; Dubrasquet M; Devissaguet JP; Puisieux F; Benita S Drug Des Deliv; 1989 Jun; 4(4):295-302. PubMed ID: 2775449 [TBL] [Abstract][Full Text] [Related]
8. Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles. Mesiha MS; Sidhom MB; Fasipe B Int J Pharm; 2005 Jan; 288(2):289-93. PubMed ID: 15620869 [TBL] [Abstract][Full Text] [Related]
9. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides. Lambert G; Fattal E; Pinto-Alphandary H; Gulik A; Couvreur P Int J Pharm; 2001 Feb; 214(1-2):13-6. PubMed ID: 11282229 [TBL] [Abstract][Full Text] [Related]
10. Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. Aboubakar M; Puisieux F; Couvreur P; Deyme M; Vauthier C J Biomed Mater Res; 1999 Dec; 47(4):568-76. PubMed ID: 10497293 [TBL] [Abstract][Full Text] [Related]
11. Physico-chemical characterization of insulin-loaded poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. Aboubakar M; Puisieux F; Couvreur P; Vauthier C Int J Pharm; 1999 Jun; 183(1):63-6. PubMed ID: 10361156 [TBL] [Abstract][Full Text] [Related]
12. Physico-chemical characterization and in vivo evaluation of indomethacin ethyl ester-loaded nanocapsules by PCS, TEM, SAXS, interfacial alkaline hydrolysis and antiedematogenic activity. Cruz L; Schaffazick SR; Dalla Costa T; Soares LU; Mezzalira G; da Silveira NP; Schapoval EE; Pohlmann AR; Guterres SS J Nanosci Nanotechnol; 2006; 6(9-10):3154-62. PubMed ID: 17048531 [TBL] [Abstract][Full Text] [Related]
13. Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats. Lowe PJ; Temple CS J Pharm Pharmacol; 1994 Jul; 46(7):547-52. PubMed ID: 7996380 [TBL] [Abstract][Full Text] [Related]
14. Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration. Rodrigues SF; Fiel LA; Shimada AL; Pereira NR; Guterres SS; Pohlmann AR; Farsky SH J Biomed Nanotechnol; 2016 May; 12(5):986-1000. PubMed ID: 27305820 [TBL] [Abstract][Full Text] [Related]
18. Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model. Bernardi A; Braganhol E; Jäger E; Figueiró F; Edelweiss MI; Pohlmann AR; Guterres SS; Battastini AM Cancer Lett; 2009 Aug; 281(1):53-63. PubMed ID: 19286307 [TBL] [Abstract][Full Text] [Related]
19. Alkaline hydrolysis as a tool to determine the association form of indomethacin in nanocapsules prepared with poly(eta-caprolactone). Pohlmann AR; Soares LU; Cruz L; da Silveira NP; Guterres SS Curr Drug Deliv; 2004 Apr; 1(2):103-10. PubMed ID: 16305375 [TBL] [Abstract][Full Text] [Related]
20. Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study. Bernardi A; Frozza RL; Jäger E; Figueiró F; Bavaresco L; Salbego C; Pohlmann AR; Guterres SS; Battastini AM Eur J Pharmacol; 2008 May; 586(1-3):24-34. PubMed ID: 18371953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]